These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16143490)

  • 1. Polysulfated sialic acid derivatives as anti-human immunodeficiency virus.
    Terada M; Fujita S; Suda I; Mastico R
    Biomed Pharmacother; 2005 Sep; 59(8):423-9. PubMed ID: 16143490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanistic effect of NMSO3 on replication of human immunodeficiency virus.
    Nakamura M; Terada M; Kamada M; Yokono A; Nakamori S; Ohno T
    Antivir Chem Chemother; 2003 Jul; 14(4):171-6. PubMed ID: 14582845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type I interferon is a powerful inhibitor of in vivo HIV-1 infection and preserves human CD4(+) T cells from virus-induced depletion in SCID mice transplanted with human cells.
    Lapenta C; Santini SM; Proietti E; Rizza P; Logozzi M; Spada M; Parlato S; Fais S; Pitha PM; Belardelli F
    Virology; 1999 Oct; 263(1):78-88. PubMed ID: 10544084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pertussis toxin B-oligomer inhibits HIV infection and replication in hu-PBL-SCID mice.
    Lapenta C; Spada M; Santini SM; Racca S; Dorigatti F; Poli G; Belardelli F; Alfano M
    Int Immunol; 2005 Apr; 17(4):469-75. PubMed ID: 15746245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockage of HIV-1 production through inhibition of proviral DNA synthesis by N,O-didecanoyl serinal dimethylacetal.
    Takamune N; Misumi S; Furuishi K; Shoji S
    IUBMB Life; 1999 Sep; 48(3):311-5. PubMed ID: 10690644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and characterization of NMSO3-resistant mutants of respiratory syncytial virus.
    Kimura K; Ishioka K; Hashimoto K; Mori S; Suzutani T; Bowlin TL; Shigeta S
    Antiviral Res; 2004 Mar; 61(3):165-71. PubMed ID: 15168797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific targeting highly conserved residues in the HIV-1 reverse transcriptase primer grip region. Design, synthesis, and biological evaluation of novel, potent, and broad spectrum NNRTIs with antiviral activity.
    Fattorusso C; Gemma S; Butini S; Huleatt P; Catalanotti B; Persico M; De Angelis M; Fiorini I; Nacci V; Ramunno A; Rodriquez M; Greco G; Novellino E; Bergamini A; Marini S; Coletta M; Maga G; Spadari S; Campiani G
    J Med Chem; 2005 Nov; 48(23):7153-65. PubMed ID: 16279773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-momorcharin inhibits HIV-1 replication in acutely but not chronically infected T-lymphocytes.
    Zheng YT; Ben KL; Jin SW
    Zhongguo Yao Li Xue Bao; 1999 Mar; 20(3):239-43. PubMed ID: 10452099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel heme-containing protein with anti-HIV-1 activity from skin secretions of Bufo andrewsi.
    Zhao Y; Jin Y; Wang JH; Wang RR; Yang LM; Lee WH; Zheng YT; Zhang Y
    Toxicon; 2005 Nov; 46(6):619-24. PubMed ID: 16157359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elimination of HIV-1 infection by treatment with a doxorubicin-conjugated anti-envelope antibody.
    Johansson S; Goldenberg DM; Griffiths GL; Wahren B; Hinkula J
    AIDS; 2006 Oct; 20(15):1911-5. PubMed ID: 16988511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-human immunodeficiency virus type 1 (HIV-1) activity of lectins from Narcissus species.
    López S; Armand-Ugon M; Bastida J; Viladomat F; Esté JA; Stewart D; Codina C
    Planta Med; 2003 Feb; 69(2):109-12. PubMed ID: 12624813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyanovirin-N potently inhibits human immunodeficiency virus type 1 infection in cellular and cervical explant models.
    Buffa V; Stieh D; Mamhood N; Hu Q; Fletcher P; Shattock RJ
    J Gen Virol; 2009 Jan; 90(Pt 1):234-43. PubMed ID: 19088294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved synthesis and pharmacological evaluation of racemic 11 -demethylcalanolide A.
    Wang L; Zhang XQ; Chen HS; Tao PZ; Li Y; Bai Y; Hu JP; Ma T; Xing ZT; Peng ZG; Zhou CM; Gao Q; Liu G
    Yao Xue Xue Bao; 2008 Jul; 43(7):707-18. PubMed ID: 18819474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by NMSO3 in tissue culture assays.
    Wyde PR; Moylett EH; Chetty SN; Jewell A; Bowlin TL; Piedra PA
    Antiviral Res; 2004 Jul; 63(1):51-9. PubMed ID: 15196820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of zidovudine prodrugs with broad-spectrum chemotherapeutic properties for the effective treatment of HIV/AIDS.
    Sriram D; Srichakravarthy N; Bal TR; Yogeeswari P
    Biomed Pharmacother; 2005 Sep; 59(8):452-5. PubMed ID: 16154314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of 2,5-dimethoxy-substituted 5-bromopyridyl thiourea (PHI-236) as a potent broad-spectrum anti-human immunodeficiency virus microbicide.
    D'Cruz OJ; Uckun FM
    Mol Hum Reprod; 2005 Oct; 11(10):767-77. PubMed ID: 16254003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent inhibition of HIV-1 replication by backbone cyclic peptides bearing the Rev arginine rich motif.
    Chaloin L; Smagulova F; Hariton-Gazal E; Briant L; Loyter A; Devaux C
    J Biomed Sci; 2007 Sep; 14(5):565-84. PubMed ID: 17520355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An inhibitor of c-Jun N-terminal kinases (CEP-11004) counteracts the anti-HIV-1 action of trichosanthin.
    Ouyang DY; Chan H; Wang YY; Huang H; Tam SC; Zheng YT
    Biochem Biophys Res Commun; 2006 Jan; 339(1):25-9. PubMed ID: 16289100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stavudine-loaded mannosylated liposomes: in-vitro anti-HIV-I activity, tissue distribution and pharmacokinetics.
    Garg M; Asthana A; Agashe HB; Agrawal GP; Jain NK
    J Pharm Pharmacol; 2006 May; 58(5):605-16. PubMed ID: 16640829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicity, inflammation, and anti-human immunodeficiency virus type 1 activity following exposure to chemical moieties of C31G.
    Catalone BJ; Miller SR; Ferguson ML; Malamud D; Kish-Catalone T; Thakkar NJ; Krebs FC; Howett MK; Wigdahl B
    Biomed Pharmacother; 2005 Sep; 59(8):430-7. PubMed ID: 16154721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.